Skip to main content

Scientists Turn Brain Cells into Alzheimer's Plaque Cleaners

Published on June 23, 2026, 7:06 p.m.
Scientists Turn Brain Cells into Alzheimer's Plaque Cleaners

Topic: Health

Researchers created a new treatment that can remove harmful proteins from the brain, potentially slowing down Alzheimer's disease. This breakthrough could lead to more effective and less frequent treatments.

Alzheimer's disease is a leading cause of dementia. Scientists have been working on new treatments to slow it down. Recently, researchers at Washington University School of Medicine in St. Louis made a big discovery. They found a way to turn brain cells into plaque cleaners. This could lead to more effective and less frequent treatments for Alzheimer's patients.

The new treatment uses a type of cell called astrocytes. Astrocytes are like cleaning cells in the brain. Scientists modified these cells to target and remove harmful proteins that contribute to cognitive decline.

In mice, this therapy prevented amyloid plaques from forming when given before plaque buildup began. When the treatment was given to mice that already had plaques, it reduced the amount of amyloid in the brain by about half.

Why It Matters

This breakthrough could lead to more effective and less frequent treatments for Alzheimer's patients. As India's population ages, understanding and addressing neurodegenerative diseases like Alzheimer's is crucial for our country's healthcare system.

Key Facts

  • Scientists at Washington University School of Medicine in St. Louis created a new treatment that can remove harmful proteins from the brain.
  • The treatment uses modified astrocytes to target and remove amyloid plaques, which contribute to cognitive decline.
  • In mice, this therapy prevented amyloid plaques from forming when given before plaque buildup began.

Key Terms

Amyloid
A sticky protein that accumulates in the brain and forms plaques

Implications

This breakthrough could lead to more effective and less frequent treatments for Alzheimer's patients. As India's population ages, understanding and addressing neurodegenerative diseases like Alzheimer's is crucial for our country's healthcare system.


Source: https://www.sciencedaily.com/releases/2026/03/260311004720.htm

Journal Reference:

  1. Yun Chen, Yizhou Liu, Khai Nguyen, Junjie Wu, Sihui Song, Kent Lin, Patrick F. Rodrigues, Siling Du, Charles Zhou, Kyle Xiong, Megan Bosch, Peter Bor-Chian Lin, Darya Khantakova, Shitong Wu, May Wu, Carla Yuede, David M. Holtzman, Marco Colonna. Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy. Science, 2026; 391 (6789) DOI: 10.1126/science.ads3972

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.